Active ingredientTemozolomideCat. No. P-T046-001CAS 85622-93-1Family · Pharmaceutical analytical standards
Temozolomide
An oral alkylating agent developed by Malcolm Stevens and his team at Aston University in Birmingham. Approved in 1999 in Europe and the United States, it is used mainly against glioblastoma and other brain tumours. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards and other impurities.
Did you know?It does not need the liver to become active: at the body's pH it opens up spontaneously into its active form, and it crosses the blood-brain barrier easily, reaching the brain.
Go to the active ingredient →Active ingredientTemozolomideCat. No. P-T046-001CAS 85622-93-1
Pharmacopoeial impurityTemozolomide EP Impurity BCat. No. P-T046-002CAS 113942-30-6
Pharmacopoeial impurityTemozolomide EP Impurity CCat. No. P-T046-003CAS 114601-31-9
Pharmacopoeial impurityTemozolomide EP Impurity DCat. No. P-T046-004CAS 7008-85-7
Pharmacopoeial impurityTemozolomide USP Related Compound BCat. No. P-T046-005CAS 13114-72-2
Pharmacopoeial impurityTemozolomide USP Related Compound CCat. No. P-T046-006CAS 83-01-2
MetaboliteTemozolomide Metabolite-MTICCat. No. P-T046-008CAS 3413-72-7
Isotopically labelledTemozolomide Metabolite-MTIC-d3Cat. No. P-T046-010CAS 1185242-69-6
Isotopically labelledTemozolomide-d3Cat. No. P-T046-011CAS 208107-14-6
Impurity1-Methyl-3-phenylureaCat. No. P-T046-012CAS 1007-36-9
Impurity2,3-Diaminomaleic acidCat. No. P-T046-013CAS 128191-80-0
ImpurityTemozolomide Impurity 1 HydrochlorideCat. No. P-T046-014CAS 6285-64-9
ImpurityTemozolomide Impurity 2Cat. No. P-T046-015CAS 287964-59-4
Impurity4,5-Dicyano-1H-(1,2,3)triazoleCat. No. P-T046-016CAS 1114912-01-4
ImpurityTemozolomide Impurity 3Cat. No. P-T046-017CAS 90801-87-9
Impurity5-Amino-1H-imidazole-4-carboxylic acidCat. No. P-T046-018CAS 4919-04-4
ImpurityTemozolomide Impurity 4Cat. No. P-T046-019CAS 188612-53-5
Impurity5-Diazoimidazole-4-carbonitrileCat. No. P-T046-020CAS 57052-92-3
ImpurityBenzenediazonium chlorideCat. No. P-T046-021CAS 100-34-5
ImpurityDiaminomaleonitrileCat. No. P-T046-022CAS 1187-42-4
ImpurityTemozolomide Impurity 5Cat. No. P-T046-023CAS 71749-37-6
ImpurityTemozolomide Impurity 6Cat. No. P-T046-025
ImpurityTemozolomide Impurity 7Cat. No. P-T046-026CAS 1822762-32-2
ImpurityTemozolomide Impurity 8Cat. No. P-T046-027
ImpurityTemozolomide Impurity 9Cat. No. P-T046-028
ImpurityTemozolomide Impurity 10Cat. No. P-T046-029
ImpurityTemozolomide Impurity 11Cat. No. P-T046-030
ImpurityTemozolomide Impurity 11 FormateCat. No. P-T046-031
ImpurityTemozolomide Impurity 12Cat. No. P-T046-032
ImpurityTemozolomide Impurity 13Cat. No. P-T046-033
ImpurityTemozolomide Impurity 14Cat. No. P-T046-034CAS 196806-10-7
ImpurityTemozolomide Impurity 15Cat. No. P-T046-035No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceTemozolomide CRSEDQM code Y0001827Family TemozolomideNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.